Seeing Is Believing
ENLV is currently covered by 1 analysts with an average price target of $80. This is a potential upside of $326.19 (5342.18%) from yesterday's end of day stock price of $1.47.
Enlivex Therapeutics Ltd's activity chart (see below) currently has 14 price targets and 20 ratings on display. The stock rating distribution of ENLV is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 23.08% with an average time for these price targets to be met of 179.33 days.
Highest price target for ENLV is $80, Lowest price target is $80, average price target is $80.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Aug-2026. First documented stock forecast 17-Feb-2015.
Currently out of the existing stock ratings of ENLV, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jan-2020
$80
$78.42 (4963.29%)
$20
Buy Since 29-Oct-2025
$13
Buy Since 17-Feb-2015
$960
$958.95 (91328.57%)
$1472
What is ENLV (Enlivex Therapeutics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the current lower performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most bullish on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most reserved on ENLV (Enlivex Therapeutics Ltd)?